Results

Vir Biotechnology Inc.

12/02/2021 | Press release | Distributed by Public on 12/02/2021 01:12

Preclinical Data Demonstrate Sotrovimab Retains Activity Against Key Omicron Mutations, New SARS-CoV-2 Variant